The McPherson’s Ltd (ASX:MCP) share price is on the move today after revealing the sudden departure of its CEO after a difficult year…
The post Why the McPherson’s (ASX:MCP) share price is sinking lower again appeared first on The Motley Fool Australia. –
The McPherson’s Ltd (ASX: MCP) share price is dropping lower again on Thursday.
At the time of writing, the health, wellness, and beauty products company’s shares are down 6.5% to $1.17.
This means the McPherson’s share price is now down over 65% from its 52-week high of $3.40.
What did McPherson’s announce?
This morning the company announced that its Chief Executive Officer and Managing Director, Laurie McAllister, has resigned with immediate effect.
This follows a dreadful year for McPherson’s which has seen the company’s performance and share price deteriorate materially.
What happened this year?
During the first quarter of FY 2021, the company recorded a decent 4% lift in sales to $49.7 million.
However, it appears as though it tried to take advantage of the incredible demand for hand sanitiser at the height of the pandemic and this ultimately backfired.
While McPherson’s reported an 84% lift in underlying profit before tax to $2.9 million, this excludes a hefty $5.7 million non-recurring full provision for the write down of its hand sanitiser inventory.
Management advised that delays in the supply of hand sanitiser products led to a customer cancelling the majority of its orders. This left it with a significant quantity of product.
Since then, the strong demand has dissipated and the supply base for such products has become much more competitive. As a result, McPherson’s has been left holding excess quantities of hand sanitiser inventory.
Unfortunately, it went from bad to worse from there. At the start of December, the company revealed that its Chinese Singles’ Day sales fell well short of target.
Once again, this left its China joint venture partner, Access Brands Management (ABM), with higher than forecast inventory levels at the end of November.
As a result of this, the company was forced to withdraw its guidance.
McPherson’s has revealed that Non-Executive Director, Grant Peck, will replace Mr McAllister on an interim basis, effective today. It feels this will provide continuity and aid the transition to a new permanent CEO and Managing Director.
This continuity will be very important given that it only completed the acquisition of the Global Therapeutics business from Blackmores Limited (ASX: BKL) on 1 December.
The board advised that it will now initiate the necessary steps to identify and appoint a permanent CEO and Managing Director and will make a further announcement in due course.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of June 30th
- Why Adore Beauty, Bank of Queensland, Bega Cheese, & McPherson’s are dropping lower
- Why is the McPherson’s (ASX:MCP) share price dropping 35% today?
- Why these All Ords shares have been smashed this month
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Blackmores Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.